Cargando…
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer
BACKGROUND: Resistance to chemotherapy is the most common cause of treatment failure in acute myeloid leukemia (AML) and the drug efflux pump ABCB1 is a critical mediator. Recent studies have identified promoter translocations as common drivers of high ABCB1 expression in recurrent, chemotherapy-tre...
Autores principales: | Williams, Mark S., Basma, Naseer J., Amaral, Fabio M. R., Williams, Gillian, Weightman, John P., Breitwieser, Wolfgang, Nelson, Louisa, Taylor, Stephen S., Wiseman, Daniel H., Somervaille, Tim C. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654162/ https://www.ncbi.nlm.nih.gov/pubmed/33167906 http://dx.doi.org/10.1186/s12885-020-07571-0 |
Ejemplares similares
-
Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity
por: Williams, Mark S., et al.
Publicado: (2021) -
A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia
por: Williams, Mark S., et al.
Publicado: (2020) -
Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia
por: Deb, Gauri, et al.
Publicado: (2019) -
DNA Translocations through Solid-State Plasmonic Nanopores
por: Nicoli, Francesca, et al.
Publicado: (2014) -
Polymer Translocation and Nanopore Sequencing: A Review of Advances and Challenges
por: Singh, Swarn Lata, et al.
Publicado: (2023)